A phase I study of combination of intravenous gemcitabine, oxaliplatin, and 5-FU with daily oral thalidomide (GOFT) in metastatic/locally advanced pancreatic carcinoma patients.

Shan, Yan-Shen

A phase I study of combination of intravenous gemcitabine, oxaliplatin, and 5-FU with daily oral thalidomide (GOFT) in metastatic/locally advanced pancreatic carcinoma patients. [electronic resource] - Hepato-gastroenterology - 2141-5 p. digital

Publication Type: Clinical Trial, Phase I; Journal Article

0172-6390


Aged
Angiogenesis Inhibitors--administration & dosage
Antimetabolites, Antineoplastic--administration & dosage
Antineoplastic Agents--administration & dosage
Deoxycytidine--administration & dosage
Drug Therapy, Combination
Female
Fluorouracil--administration & dosage
Humans
Infusions, Intravenous
Liver Neoplasms--secondary
Male
Maximum Tolerated Dose
Middle Aged
Organoplatinum Compounds--administration & dosage
Oxaliplatin
Pancreatic Neoplasms--drug therapy
Thalidomide--administration & dosage
Tomography, X-Ray Computed
Gemcitabine